{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:01:15Z","timestamp":1759482075110},"reference-count":34,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.08.029","type":"journal-article","created":{"date-parts":[[2007,9,5]],"date-time":"2007-09-05T11:24:06Z","timestamp":1188991446000},"page":"7832-7840","source":"Crossref","is-referenced-by-count":38,"title":["Failure of a Mycobacterium tuberculosis \u0394RD1 \u0394panCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: Comparisons to responses elicited by M. bovis bacille Calmette Guerin"],"prefix":"10.1016","volume":"25","author":[{"given":"W. Ray","family":"Waters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell V.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Nonnecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler C.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles F. Capinos","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Mark","family":"Estes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aharona","family":"Glatman-Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle H.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2007.08.029_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/79631","article-title":"Is the development of a new tuberculosis vaccine possible?","volume":"6","author":"Kaufman","year":"2000","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.029_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm0496-430","article-title":"The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease","volume":"2","author":"Walsh","year":"1996","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.029_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri1666","article-title":"Immune responses to tuberculosis in developing countries: implications for new vaccines","volume":"5","author":"Rook","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.029_bib4","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/IAI.71.11.6411-6419.2003","article-title":"Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination","volume":"71","author":"Buddle","year":"2003","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.029_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2249.2005.02668.x","article-title":"Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis","volume":"139","author":"Hope","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.08.029_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3168\/jds.S0022-0302(05)72678-3","article-title":"Development of an adult-like cell-mediated immune response in calves after early vaccination with Mycobacterium bovis bacillus Calmette-Guerin","volume":"88","author":"Nonnecke","year":"2005","journal-title":"J Dairy Sci"},{"key":"10.1016\/j.vaccine.2007.08.029_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3168\/jds.S0022-0302(07)72641-3","article-title":"High growth rate fails to enhance adaptive immune responses of neonatal calves and is associated with reduced lymphocyte viability","volume":"90","author":"Foote","year":"2007","journal-title":"J Dairy Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.029_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tube.2006.03.001","article-title":"Mycobacterium bovis in rural Tanzania: risk factors for infection in human and cattle populations","volume":"87","author":"Cleaveland","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2007.08.029_bib9","first-page":"605","article-title":"Human tuberculosis caused by Mycobacterium bovis \u2013 New York City, 2001\u20132004","volume":"54","author":"Winters","year":"2005","journal-title":"Morbid Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.029_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.029_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.029_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1086\/345862","article-title":"Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation","volume":"187","author":"Lewis","year":"2003","journal-title":"J Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2007.08.029_bib13","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1635213100","article-title":"The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue","volume":"100","author":"Hsu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.08.029_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.micinf.2005.04.001","article-title":"Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis","volume":"7","author":"Sambandamurthy","year":"2005","journal-title":"Microbes Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.029_bib15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nm765","article-title":"A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis","volume":"8","author":"Sambandamurthy","year":"2002","journal-title":"Nat Med"},{"issue":"37\u201339","key":"10.1016\/j.vaccine.2007.08.029_bib16","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis \u0394RD1 \u0394panCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.029_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7589\/0090-3558-33.4.749","article-title":"Bovine tuberculosis in free-ranging white-tailed deer from Michigan","volume":"33","author":"Schmitt","year":"1997","journal-title":"J Wildl Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.029_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1054\/tube.2002.0341","article-title":"Aerosol delivery of virulent Mycobacterium bovis to cattle","volume":"82","author":"Palmer","year":"2002","journal-title":"Tuberculosis (Edinb)"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.029_bib19","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","article-title":"Correlation of ESAT-6 specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis","volume":"70","author":"Vordermeier","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.08.029_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0962-8479(97)90016-2","article-title":"Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis","volume":"78","author":"Rhoades","year":"1997","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.vaccine.2007.08.029_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcpa.2005.05.001","article-title":"Advanced granulomatous lesions in Mycobacterium bovis-infected cattle are associated with increased expression of type I procollagen, \u03b3\/\u03b4 (WC1+) T cells and CD68+ cells","volume":"133","author":"Wangoo","year":"2005","journal-title":"J Comp Pathol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.029_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.vaccine.2004.07.019","article-title":"CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis","volume":"23","author":"Maue","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.029_bib23","series-title":"Bioinformatics methods and protocols: methods in molecular biology","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","author":"Rozen","year":"2000"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.029_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.029_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/IAI.71.1.317-326.2003","article-title":"Expression of l-selectin (CD62L), CD44, and CD25 on activated bovine T cells","volume":"71","author":"Waters","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.08.029_bib26","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/JCM.34.11.2795-2802.1996","article-title":"Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria","volume":"34","author":"Glatman-Freedman","year":"1996","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.029_bib27","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","article-title":"Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy","volume":"174","author":"Dietrich","year":"2005","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.08.029_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-2427(98)00081-6","article-title":"Bovine type 1 and type 2 responses","volume":"63","author":"Brown","year":"1998","journal-title":"Vet Immunol Immunopathol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.08.029_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00201-5","article-title":"Type 1 and type 2 responses in regulation of Ig isotype expression in cattle","volume":"90","author":"Estes","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.029_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2006.11.009","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease","volume":"123","author":"Chen","year":"2007","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.08.029_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.it.2004.06.005","article-title":"IL-4 in tuberculosis: implications for vaccine design","volume":"25","author":"Rook","year":"2004","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.029_bib32","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.178.6.3688","article-title":"Messenger RNA expression of IL-8, FOXP3, and IL-12beta differentiates latent tuberculosis infection from disease","volume":"178","author":"Wu","year":"2007","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.029_bib33","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1164\/rccm.200508-1294OC","article-title":"Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis","volume":"173","author":"Guyot-Revol","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2007.08.029_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2958.2004.04183.x","article-title":"Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response","volume":"53","author":"Briken","year":"2004","journal-title":"Mol Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T09:10:47Z","timestamp":1587892247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":34,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07009656"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}